secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2025-11-25T23:59:59+00:00
Accession:  0001640334-25-002210
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences receives Nasdaq delisting notice; plans to appeal
--------------------------------------------------------------------

- Received delist determination on Nov 19, 2025 for non-compliance with equity rule (min $2.5M stockholders' equity).
- Submitted compliance plans on July 7 and Aug 29, 2025, but did not complete the planned capital raise.
- Unless appeal requested by Nov 26, delisting effective Dec 1, 2025; intends to appeal to Nasdaq hearing panel.
- Stock (ARTL) continues trading on Nasdaq during appeal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425002210/0001640334-25-002210-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033425002210/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-002210

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer